American Journal of Neuroradiology 20:787-789 (5 1999)
© 1999 American Society of Neuroradiology
ARTICLE
Cerebral Angioplasty and Stenting for Intracranial Vertebral Atherosclerotic Stenosis
a From the Division of Neurological Endovascular Intervention, Department of Neurosurgery, Kochi Medical School Hospital, Japan.
| Abstract |
|---|
|
|
|---|
Summary: A 72-year-old man underwent cerebral angioplasty and stenting for a high-grade eccentric atherosclerotic stenosis (93%) of the right intracranial vertebral artery. The lesion was sufficiently and smoothly dilated very easily with the use of a highly flexible, balloon-expandable coronary stent. No complications occurred during or after the procedure. This therapeutic option may prove to be a safe and useful means to resolve an intracranial atherosclerotic stenosis.
| Introduction |
|---|
|
|
|---|
For some time, metallic stents have been used in the coronary and other peripheral vessels with a remarkable reduction in procedural morbidity (1), whereas it has only been in the past few years that percutaneous transluminal cerebral balloon angioplasty (PTCBA) of the intracranial artery has been reported (26). Although some studies have produced good results (2, 5), others have described a high morbidity or mortality rate after intracranial PTCBA (3, 6). We describe a case in which elective cerebral angioplasty and stenting (CAS) resolved a high-grade atherosclerotic eccentric stenosis of the intracranial vertebral artery very easily and without complications.
| Case Report |
|---|
|
|
|---|
A 72-year-old man with an unruptured aneurysm in the right middle cerebral artery and total occlusion of the left vertebral artery was referred to our institution for endovascular treatment of a high-grade (93% diameter, 4.5-mm length) eccentric stenosis of the right intracranial vertebral artery (Fig 1A and B). Although it was hoped that the aneurysm could be surgically clipped, the intracranial high-grade stenosis and total occlusion in the posterior cerebral circulation indicated too great a risk for general anesthesia. Therefore, vascular reconstruction of the intracranial stenosis, if possible under local anesthesia, was indicated to reduce the risk.
|
We attempted to use a highly flexible, stainless-steel (316L) stent to dilate firmly the lesion, as arterial dissection or abrupt closure was possible with this extremely eccentric lesion. The Ministry of Health and Welfare in Japan has approved the gfx stent (AVE Inc, Santa Rosa, CA) for the coronary artery, but has not yet approved it for the cerebral artery. The president of our institution, however, permitted us to use the coronary stent for the cerebral artery in this patient, after the patient gave informed written consent for CAS.
We administered 200 mg of ticlopidine per day starting 1 day before CAS. The stenosis rate was calculated from angiograms before and immediately after CAS by using the North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria, which compares the diameter at the site of greatest narrowing with the diameter of a normal artery distal to the lesion.
The patient underwent CAS under local anesthesia. A 6F guiding catheter (MR2, Medikit Co, Tokyo, Japan) with 0.064-inch inner diameter was selectively placed via a femoral arterial route into the right vertebral artery. Low-molecular-weight dextran (1000 mL per day) was started 1 hour before CAS and continued until the next day. Heparin (10,000 U) was administered intravenously to avoid thrombus formation during the procedure, and isosorbide dinitrate (2.5 mg) was injected into the right vertebral artery through a guiding catheter to prevent balloon catheter-induced vasospasm. A 0.014-inch guidewire (Dasher-14, Boston Scientific/Target Therapeutics, Fremont, CA) was navigated across the stenosis. The very flexible balloon catheter (Ranger, Boston Scientific/SCIMED, Maple Grove, MN) with a 2.5-mm diameter and 20-mm length was guided over the wire and then inflated twice at 6 atm for 60 seconds to predilate the lesion. The balloon catheter was replaced by the balloon-expandable coronary stent (gfx) with a 3.0-mm diameter and 12-mm length (Fig 1) with the 0.014-inch 300-cm exchange guidewire (Taper-14, Boston Scientific/Target). The stent was deployed at 9 atm for 15 seconds. The lesion was sufficiently dilated very easily (Fig 1D and E), and the stenosis was reduced from 93% to 0%. No complications occurred during or after the procedure, which was finished within 60 minutes.
The patient received 200 mg of ticlopidine per day as the poststent therapeutic regimen to prevent stent thrombosis after CAS. Two days later, he returned to the presenting hospital to undergo surgical clipping of the aneurysm.
| Discussion |
|---|
|
|
|---|
Anticipation of the likelihood of a successful procedure is required before performing PTCBA. As previous studies have reported (4, 5), a short (< 5 mm in length) concentric or moderately eccentric intracranial atherosclerotic lesion is the most amenable to PTCBA, but PTCBA for a tubular lesion (510 mm in length) or an extremely eccentric lesion may lead to higher complications and restenosis. According to this classification, a lesion with an extreme eccentricity and a length of 4.5 mm, as in our case, was considered to be in the latter group. If standard PTCBA only was attempted in the latter group, a higher morbidity and restenosis rate would be anticipated. Therefore, in order to avoid abrupt closure or symptomatic dissection and retain long-term patency, we made an attempt to apply a stent to the lesion in our patient. The gfx coronary stent has good flexibility and appropriate length (12 mm) to follow arterial tortuosities and can conform to vascular morphology. In addition, its crown-shaped struts with wide openings do not seem to occlude side branches, such as perforating arteries. We therefore decided to use the gfx stent. We also used the coronary balloon catheter (Ranger), which has good flexibility and trackability and an over-the-wire system for dilatation prior to stenting.
Coronary artery stenting has been widely evaluated for the treatment of stenoses (7). Several articles have reported efficacy of bailout stenting after failed coronary angioplasty (1); however, no stent has been specifically designed for an intracranial atherosclerotic stenosis. Previous studies (8, 9) have reported the application and efficacy of other coronary metallic stents to an atherosclerotic petrous carotid artery. In addition, carotid artery stenting is currently being evaluated (10, 11). However, as far as we know, there is as yet no report of elective CAS for an atherosclerotic intracranial artery.
| Conclusion |
|---|
|
|
|---|
CAS may prove to be a safe and useful means to resolve an intracranial atherosclerotic stenosis in similar situations. This initial result for CAS is encouraging and warrants further investigation.
| Acknowledgments |
|---|
We thank Louise E. Johnstone, Department of Physiology, Kochi Medical School, for proofreading the manuscript.
| Footnotes |
|---|
101 Address reprint requests to Takahisa Mori, MD, PhD, Division of Neurological Endovascular Intervention, Department of Neurosurgery, Kochi Medical School Hospital, Kohasu, Okou-tyo, Nankoku City, Kochi 7838505, Japan.
| References |
|---|
|
|
|---|
- Altmann DB, Racz M, Battleman DS,, et al. Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients. Am Heart J 1996;132:503-507[Medline]
-
Clark WM, Barnwell SL, Nesbit G, O'Neil OR, Wynn ML, Coull BM. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995;26:1200-1204
[Abstract/Free Full Text] - Higashida RT, Tsai FY, Halbach VV, Dowd CF, Hieshima GB. Cerebral percutaneous transluminal angioplasty. Heart Dis Stroke 1993;2:497-502[Medline]
- Mori T, Mori K, Fukuoka M, Arisawa M, Honda S. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology 1997;39:111-116[Medline]
- Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525-1533[Abstract]
- Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997;18:1661-1668[Abstract]
-
Fischman DL, Leon MB, Baim DS,, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: stent restenosis study investigators. N Engl J Med 1994;331:496-501
[Abstract/Free Full Text] - Dorros G, Cohn JM, Palmer LE. Stent deployment resolves a petrous carotid artery angioplasty dissection. AJNR Am J Neuroradiol 1998;19:392-394[Abstract]
- Feldman RL, Trigg L, Gaudier J, Galat J. Use of coronary Palmaz-Schatz stent in the percutaneous treatment of an intracranial carotid artery stenosis. Cathet Cardiovasc Diagn 1996;38:316-319[Medline]
- Dietrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg 1996;3:42-62[Medline]
-
Yadav JS, Roubin GS, Iyer S,, et al. Elective stenting of the extracranial carotid arteries. Circulation 1997;95:376-381
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
A. Bose, M. Hartmann, H. Henkes, H. M. Liu, M. M.H. Teng, I. Szikora, A. Berlis, J. Reul, S. C.H. Yu, M. Forsting, et al. A Novel, Self-Expanding, Nitinol Stent in Medically Refractory Intracranial Atherosclerotic Stenoses: The Wingspan Study Stroke, May 1, 2007; 38(5): 1531 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation, March 14, 2006; 113(10): e409 - e449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, February 1, 2006; 37(2): 577 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kim, B. H. Lee, D. I. Kim, W. H. Shim, P. Jeon, and T. H. Lee Stent-Assisted Angioplasty of Symptomatic Intracranial Vertebrobasilar Artery Stenosis: Feasibility and Follow-up Results AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1381 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Masuo, T. Terada, G. Walker, M. Tsuura, K. Nakai, and T. Itakura Patency of Perforating Arteries after Stent Placement? A Study Using an In Vivo Experimental Atherosclerosis-Induced Model AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 543 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J K Kim, J Y Ahn, B H Lee, Y S Chung, S S Chung, O J Kim, W C Kim, and J Y Joo Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 847 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. M. Lin, P. Gailloud, N. J. Beauchamp, E. M. Aldrich, R. J. Wityk, and K. J. Murphy Combined Stent Placement and Thrombolysis in Acute Vertebrobasilar Ischemic Stroke AJNR Am. J. Neuroradiol., October 1, 2003; 24(9): 1827 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.C. Cloud and H.S. Markus Diagnosis and management of vertebral artery stenosis QJM, January 1, 2003; 96(1): 27 - 54. [Full Text] [PDF] |
||||
![]() |
P. Lylyk, J. E. Cohen, R. Ceratto, A. Ferrario, and C. Miranda Angioplasty and Stent Placement in Intracranial Atherosclerotic Stenoses and Dissections AJNR Am. J. Neuroradiol., March 1, 2002; 23(3): 430 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Gomez and S. C. Orr Angioplasty and Stenting for Primary Treatment of Intracranial Arterial Stenoses Arch Neurol, October 1, 2001; 58(10): 1687 - 1690. [Full Text] [PDF] |
||||
![]() |
Angioplasty and Stenting of Extracranial Brachiocephalic Stenoses (Other Than the Cervical Carotid Bifurcation) and Intracranial Stenoses AJNR Am. J. Neuroradiol., September 1, 2001; 22(2007): 31S - 33S. [Full Text] [PDF] |
||||
![]() |
H. C. Nahser, H. Henkes, W. Weber, E. Berg-Dammer, T. A. Yousry, and D. Kuhne Intracranial Vertebrobasilar Stenosis:Angioplasty and Follow-up AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1293 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Gomez, V. K. Misra, M. S. Campbell, and R. D. Soto Elective Stenting of Symptomatic Middle Cerebral Artery Stenosis AJNR Am. J. Neuroradiol., May 1, 2000; 21(5): 971 - 973. [Abstract] [Full Text] |
||||
![]() |
T. Mori, K. Kazita, K. Chokyu, T. Mima, and K. Mori Short-Term Arteriographic and Clinical Outcome after Cerebral Angioplasty and Stenting for Intracranial Vertebrobasilar and Carotid AtheroscleroticOcclusive Disease AJNR Am. J. Neuroradiol., February 1, 2000; 21(2): 249 - 254. [Abstract] [Full Text] |
||||
![]() |
C. R. Gomez, V. K. Misra, M. W. Liu, V. R. Wadlington, J. B. Terry, R. Tulyapronchote, and M. S. Campbell Elective Stenting of Symptomatic Basilar Artery Stenosis Stroke, January 1, 2000; 31(1): 95 - 99. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






